Quarterly report · Q3
4021.TEDINET S100Q6HC
Period2022-04-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥159.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥141.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥38.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥33.9bn | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥35.8bn | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥41.3bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥36.0bn | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥30.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥25.6bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥31.0bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥25.9bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥276.6bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥279.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥254.7bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.4bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥71.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥216.2bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥208.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥199.4bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥25.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥25.9bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥25.2bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥37.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥35.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥13.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.8bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥37.5bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥35.5bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥217.99 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.21 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥179.58 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.51 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 77.1% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥19.1bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥8.2bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥11.0bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥343m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥80.6bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-12-31 | −¥22.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥58.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥4.1bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥48.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥40.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥8.4bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥15.2bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥29.9bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥20.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥9.4bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥62.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥50.6bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥12.0bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥20.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.8bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥10m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥74.7bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥57.1bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥17.6bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥239.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥181.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥58.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥42.9bn |
| Otherother segments | revenue | 2021-04-01 → 2021-12-31 | ¥16.5bn |
| Otherother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥7.1bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9.4bn |
| Otherother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥193m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥64.0bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-12-31 | −¥16.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥47.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥3.8bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥36.9bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥32.0bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥4.9bn |
| jpcrp040300-q3r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥9.9bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥27.6bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥19.1bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥8.5bn |
| jpcrp040300-q3r_E00759-000Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥60.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥51.5bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥9.0bn |
| jpcrp040300-q3r_E00759-000Functional Materialsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥20.7bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥5.3bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥5.2bn |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥35m |
| jpcrp040300-q3r_E00759-000Medicinesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.3bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥58.6bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥42.8bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥15.8bn |
| jpcrp040300-q3r_E00759-000Wholesalereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥205.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥157.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥47.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥37.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 529
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in financing activities | CurrentYTDDuration | -37506000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 52000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 1364000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -7225000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -11845000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 32380000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 34658000000 | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YTDDuration | － | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYTDDuration | 3116000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 25155000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 25928000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00759-000ChemicalProductsReportableSegmentsMember | 19051000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00759-000FunctionalMaterialsReportableSegmentsMember | 51502000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 31956000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00759-000MedicinesReportableSegmentsMember | 5228000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E00759-000WholesaleReportableSegmentsMember | 42829000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OtherReportableSegmentsMember | 7123000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 157692000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | -16354000000 | JPY |
| Revenues from external customers | Prior1YTDDuration | 141337000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00759-000ChemicalProductsReportableSegmentsMember | 8505000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00759-000FunctionalMaterialsReportableSegmentsMember | 9013000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 4924000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00759-000MedicinesReportableSegmentsMember | 35000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E00759-000WholesaleReportableSegmentsMember | 15793000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OtherReportableSegmentsMember | 9360000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 47632000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -47632000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00759-000ChemicalProductsReportableSegmentsMember | 27557000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00759-000FunctionalMaterialsReportableSegmentsMember | 60515000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 36880000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00759-000MedicinesReportableSegmentsMember | 5263000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E00759-000WholesaleReportableSegmentsMember | 58623000000 | JPY |
| Net sales | Prior1YTDDuration_OtherReportableSegmentsMember | 16484000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 205324000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -63986000000 | JPY |
| Net sales | Prior1YTDDuration | 141337000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00759-000ChemicalProductsReportableSegmentsMember | 2458000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00759-000FunctionalMaterialsReportableSegmentsMember | 20709000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 9915000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00759-000MedicinesReportableSegmentsMember | 2300000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E00759-000WholesaleReportableSegmentsMember | 2136000000 | JPY |
| Operating income | Prior1YTDDuration_OtherReportableSegmentsMember | 193000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 37712000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -3777000000 | JPY |
| Operating income | Prior1YTDDuration | 33935000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00759-000ChemicalProductsReportableSegmentsMember | 20461000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00759-000FunctionalMaterialsReportableSegmentsMember | 50562000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E00759-000AgriculturalChemicalProductsReportableSegmentsMember | 40400000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |